Latest News
-

Sheep leading the flock: metabolism and biomarkers in HD
⏱️ 8 min read
Sheep can help us to identify HD biomarkers and recognize metabolic changes that occur before symptoms develop.
-

Weeding out the truth: can cannabis improve Huntington’s?
⏱️ 8 min read
What can individual experiences with cannabis tell us about Huntington's disease?
-

Huntingtin grabs a hammer: DNA repair in HD
⏱️ 8 min read
Huntingtin helps fix damaged DNA, a recent study suggests, under the direction of a gene repair protein called ATM.
-

The benefits of migration, highlighted in Huntington's disease
⏱️ 6 min read
Is HD a developmental disease? HD stops neurons migrating in developing brain, but maybe we can get them going again
-

Treasure your exceptions – using outliers to understand Huntington's disease onset and progression
⏱️ 7 min read
A new study provides the framework for finding factors that affect the onset and progression of HD
-

A powerful message: does a toxic RNA message molecule cause harm in Huntington's disease?
⏱️ 7 min read
What if some problems in HD were due to something other than a harmful protein?
-

Pfizer Amaryllis trial ends in disappointment: no improvement in Huntington's disease symptoms
⏱️ 4 min read
Pfizer announces the 'Amaryllis' trial of a PDE-10 inhibitor drug failed to improve symptoms of HD
-

Important advances in next generation genome editing tools for Huntington's Disease
⏱️ 13 min read
Work with genome editing techniques (zinc fingers and CRISPR) brings these tools closer to use in HD clinical trials
-

Sorry folks, the PRIDE-HD trial did NOT show that Pridopidine slows the progression of Huntington's disease
⏱️ 13 min read
HDBuzz helps untangle some bold claims about the just-announced results of the PRIDE-HD trial of pridopidine in HD
-

EuroBuzz 2016: The Euro-HD Network Meeting in The Hague
⏱️ 21 min read
All our tweets from #EHDN2016 in one mega-article
HDBuzz Trial Tracker
Show 8 more Show less
Updates from the ongoing Phase 3 INVEST-HD trial of votoplam
Updates from the Phase 1b/2a REGEN4HD trial of neural stem cell therapy hNSC-01
Updates from the ongoing Phase 2/3 FALCON-HD trial of SKY-0515
Previously featured
-
Mending the fabric of your genes
-
Could rewiring the brain’s “brakes” improve movement in Huntington’s disease?
-
Your Voice Matters: Using Speech to Monitor Huntington’s Disease
-
Can’t Get You Out of My Head: The Huntington’s Disease Symptom That’s More Than Just Repetition
-
AMT-130 at Four Years: Hopeful Signs, Complex Controls
Follow HDBuzz
Sign up to our monthly email summary by entering your email address on our mailing list page.
Suggest an article
Is there something you want us to write about? Tell us about it here. We consider all suggestions but can’t promise to write content about any particular suggestion.
